More and more women are using GLP-1 receptor agonists such as Ozempic with the active ingredient semaglutide, for example to treat type 2 diabetes or to support weight reduction. At the same time, questions arise about what to keep in mind when trying to conceive, when Ozempic and pregnancy overlap unexpectedly, or during breastfeeding. A useful starting point for context is GLP-1 agonists: indications and off-label use.
Ozempic during pregnancy: Why caution is recommended
Ozempic is not intended for use during pregnancy. The product information describes limited human data as well as reproductive toxicology findings from animal studies. If pregnancy occurs or is planned, semaglutide should be discontinued.
In clinical practice, it is important to distinguish between planned use and unintended exposure. Accidental use does not automatically mean a high-risk pregnancy. What matters is an individual medical assessment.
Stopping before a planned pregnancy: timing and rationale
For women who are trying to conceive, a safety interval is recommended. Semaglutide should be stopped at least two months before a planned pregnancy. The reason is its long half-life. Semaglutide has an elimination half-life of about one week and may remain in circulation for several weeks after the last dose.
If semaglutide is being used as Ozempic (semaglutide), any switch in therapy should be medically planned early when pregnancy is desired, so blood sugar targets and weight trends remain stable.
Becoming pregnant while on Ozempic: what’s behind “Ozempic babies”
Even though Ozempic is not recommended during pregnancy, unplanned pregnancies do occur in practice while using it. Media outlets sometimes refer to “Ozempic babies.” Professional societies point to several plausible factors:
- Weight reduction and improved metabolic markers can help normalize cycle patterns and ovulation.
- With PCOS and obesity, hormonal and metabolic changes may support fertility.
- Gastrointestinal side effects such as vomiting or diarrhea can interfere with reliable absorption of oral contraceptives.
If pregnancy is confirmed, the product information states: stop semaglutide and seek medical review. Specialized teratology counseling services can also help, including with individual risk assessment and reporting so the evidence base can improve.
Contraception on semaglutide: what is known about the pill
Women of childbearing potential are advised to use reliable contraception during treatment. The product information does not expect semaglutide to meaningfully reduce the effectiveness of combined oral contraceptives in a clinically relevant way.
In practice, there can still be risk if vomiting or diarrhea occurs. In these situations, absorption of oral contraceptives may be unreliable. A structured overview of typical side effects can help identify warning signs early, for example the therapy process and side effects before you start.
Breastfeeding and semaglutide: what currently applies
Whether semaglutide passes into breast milk is not sufficiently clarified in humans. In animal studies, semaglutide has been detected in milk. Because a risk to a breastfed infant cannot be ruled out, semaglutide should not be used while breastfeeding.
If breastfeeding is planned, treatment should be adjusted together with the treating clinician so that metabolic targets and safety during breastfeeding are both considered.
Semaglutide pregnancy: what human studies show so far
Human data are increasing but still limited. When it comes to semaglutide pregnancy, observational data and analyses from teratology information services have not shown evidence to date of a clearly increased risk of major birth defects after exposure in early pregnancy. However, they also highlight ongoing limitations in the evidence and possible confounding factors related to underlying medical conditions. This does not change the recommendation not to use Ozempic during pregnancy.
Trying to conceive: planning, alternatives, and weight management
When pregnancy is desired, clear planning is important. That includes stopping in time, using reliable contraception until then, and a coordinated plan for diabetes care and weight management.
For weight regulation, semaglutide is also used as GLP-1 therapy with Wegovy. Regardless of the product, discontinuation should not happen without preparation when trying to conceive, because weight and metabolism can change again afterward.
It can also help to plan medication and non-medication strategies separately, for example by considering metformin for weight loss and metabolic support and practical nutrition priorities such as dos and don’ts for nutrition during medication-assisted weight loss. Hormonal aspects around GLP-1 are also discussed in hormonal changes with GLP-1-related weight loss.
Conclusion
An Ozempic and pregnancy situation is often unplanned and should be assessed individually by a clinician. According to current product information, Ozempic is not recommended during pregnancy or breastfeeding. For those trying to conceive, stopping at least two months before a planned conception is recommended.
In complex situations, an appointment for medical assessment can help align medication, contraception, and timing.
FAQ
Are there alternatives to Ozempic for women trying to conceive?
Depending on the situation, other treatment options may be appropriate. In type 2 diabetes, established alternatives are often used and should be evaluated as part of pregnancy planning. The key is achieving safe blood sugar targets and planning any medication change early.
Non-medication measures such as nutrition, physical activity, and structured support remain core components, especially when semaglutide is being discontinued.
Can Ozempic pass into breast milk?
This is not sufficiently clarified in humans. In animal studies, semaglutide has been detected in milk. Because a risk to a breastfed infant cannot be ruled out, semaglutide should not be used while breastfeeding.
How long before pregnancy should Ozempic be stopped?
A minimum interval of two months before a planned pregnancy is recommended. This is related to the long half-life and how long the medication can remain in the body.
How long does it take for Ozempic to leave the body?
Semaglutide has a half-life of about one week. After the last dose, the active ingredient may remain in circulation for several weeks. This is why a safety interval of at least two months is recommended.
Sources
- EMA: Ozempic product information, sections on pregnancy, breastfeeding, pharmacokinetics
- AkdÄ: “Ozempic babies”? what the evidence shows
- DGGG: position statement on unplanned “Ozempic babies” and GLP-1 analogs preconception
- DDG: press release on fertility changes during GLP-1 therapy
- NCBI Bookshelf: Semaglutide, pharmacokinetics and elimination
Note: This article is for information only and does not replace individual medical advice.